Megairdin Tablet 2 mg (Irsolgladin Maleate)

Adult dose

1) Gastric ulcer (Adults) Irsoogladine maleate 4mg, taken orally once daily. 2) Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis (Adults) Irsoogladine maleate 4mg, taken orally in 1∼2 divided doses daily.

This drug contains lactose; therefore, it should not be used in patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Some patients may experience side effects such as liver dysfunction, constipation, rashes, itching, and diarrhea, so they should consult a physician immediately if symptoms occur. Particularly, elderly patients may have reduced body functions, so the dosage should start low and the condition should be closely monitored during administration. Women who are pregnant or may become pregnant should only use this medication if its benefits are deemed greater than the risks, as safety during pregnancy is not established. Additionally, this medication may be partially transmitted through breast milk; thus, breastfeeding women are advised to avoid administration or discontinue breastfeeding while using it. Safety in children has not been sufficiently validated, so it should be used cautiously in pediatric patients. This medication should be kept out of the reach of children, and transferring it to other containers may lead to accidents or quality degradation.

• Liver function abnormalities
• ALT (GPT) increase
• AST (GOT) increase
• constipation
• rash
• itching
• diarrhea
• ALP increase
• nausea
• vomiting

This medication is sensitive to air and moisture and should be stored in a tightly sealed container. Additionally, it is recommended to store the medication at room temperature between 1 degree and 30 degrees Celsius to maintain its efficacy for a long time.

Appearance

White round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle